Nichole Maloney, M.S.

Nichole
Maloney, M.S.
M.S.
Senior Research Specialist
nichole.maloney@vumc.org

Originally from Portland, Oregon, Nichole earned a B.S. and M.S. from University of Nevada, Reno. She supports laboratory and the VI4 operations.

Recommended Reading - March & April 2025

Suppression of Class Switch Recombination to IgA by RASA2 and RASA3 through Inhibition of TGF-β Signaling. Mamand S, et al. in Journal of Immunology, October 25, 2024The neonatal Fc receptor is a cellular receptor for human astrovirus. Ingle H, et al.

Recommended Reading - January & February 2025

Histone H1 kills MRSA. Marsman G, et al. in Cell Reports, November 14, 2024Dietary and water restriction leads to increased susceptibility to antimicrobial resistant pathogens. Lacey K, et al.

Fredrick Haywood, Jr., MBA

Fredrick
Haywood, Jr., MBA
Jr., MBA
Communications Project Manager
Vanderbilt Institute for Infection, Immunology & Inflammation (VI4) | Pathology, Microbiology and Immunology

Fredrick Haywood is the Social Media and Communications Project Manager for the Vanderbilt Institute for Infection, Immunology & Inflammation (VI4) and the Department of Pathology, Microbiology, and Immunology. In this role, he manages The Studio and the VI4/PMI social media accounts, focusing on content creation, email marketing, graphic design, website maintenance and mentoring the VI4 Science Communication Internship.

Office Address
MCN C3314A
1161 21st Ave South
Nashville
Tennessee
37232
fredrick.haywood@vumc.org

Recommended Reading - November & December 2024

1. Framework for exploring the sensory repertoire of the human gut microbiota. Ross P, et al. in mBio, May 17, 20242. Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein. Langedijk J, et al. in Nature, May 31, 2024

Douglas Mitchell, PhD

Douglas
Mitchell, PhD
William Kelly Warren Sr. Chair in Biochemistry
Professor of Chemistry, Director of Vanderbilt Institute for Chemical Biology

Our lab focuses on the discovery, biosynthesis, and re-engineering of ribosomally synthesized and post-translationally modified peptides (RiPPs). Using a genes-to-molecules approach, we leverage big data genomics analyses to inform RiPP structure and function. These efforts routinely uncover unique enzyme chemistries that constrain peptides in a manner that enables high-affinity engagement with biological targets. Our work aims to harness RiPP biosynthetic pathways to create new-to-nature compounds with novel activities to improve human health.

Keywords: chemical biology, genome mining, bioinformatics, microbial natural products, enzyme chemistry, antibiotics, drug design